Connect with Healthcetera
Wednesday, November 13, 2024
HomeStandard Blog Whole Post (Page 164)

 

Nobody's talking: New data shows just 12% of providers talk to their heart patients about end of life, while a recent CDC study suggest only 50% of patients receive education on chronic illnesses. Photo @shelserkin.

Nobody’s talking: New data shows that just 12% of providers talk to their heart patients about end of life, and a recent CDC study suggests only 50% of patients recall receiving education on their chronic illnesses. Photo @shelserkin.

A tweet caught my eye somewhere in the middle of Wednesday’s endless Twitter spin. NPR’s Health Blog, Shots headlined: “Doctors Hesitate To Ask Heart Patients About End-Of-Life Plans.” Huh. I was on my lunch break from working with cardiac patients, so I clicked in.

The blog post started with the familiar intro to congestive heart failure (CHF): a grim long-term prognosis, high incidence of hospital admissions, decreased quality of life, and likely death within five years of diagnosis. It ended with new research that suggests clinicians aren’t talking about these things with their CHF patients.

CHF is tricky. For a long time, patients feel fine; but as the disease progresses, their balance between thriving at home and succumbing to its complications in the hospital can come down to a packet of salt or a cup of water. It is the condition with the highest readmission rate, and requires exhaustive patient education about strict compliance with multiple medications and diet restrictions to keep complications at bay. Then, one day, all of the therapies stop working because the heart is just too worn out. That’s the day, the day that happens for all CHF patients, that doctors aren’t talking about, apparently.

The showcased data, yet to be published, was gathered from interviews with 100 MDs and NPs. Of the total, only a third said they were confident in even bringing up end-of-life care with their patients; 21% faulted patients’ readiness to chat, 11% of providers felt uncomfortable, and a very interesting 9% said they didn’t want to dash their patients’ sense of hope. In total, only 12% of the clinicians taking care of long-term CHF patients actually talked to them about end of life.

To be fair, practitioners aren’t reimbursed for these chats. They have to cram them into their pro-bono-goodwill budget. Maybe this is why a fraction of those in this study said they just didn’t have the time. But CHF is a disease so intimately tied to teaching patients to observe the progression of their symptoms – one pound of weight gained can mean a leap towards exacerbation – that it’s hard for me to understand how talks about prognosis and management can be separated.

It’s maleficent, really. When clinicians don’t discuss options and prognosis, patients are actually harmed by omission. Not talking fosters an unrealistic sense of cure, and patients miss out on amazing alternative options, like palliative care and hospice services. Yes, hospice is intended for patients with a six month prognosis, but the CMS-reimbursed program focuses on the management of comfort, not cure, and many patients actually improve and are discharged. Palliative care centers on maximizing symptom relief for chronic patients, like CHFers, in tandem with medical therapies. In a disease where the only real cure – heart transplant – isn’t offered to the majority of patients, therapies with the goal of maximizing quality of life are worth bringing up sooner rather than later.

One of the authors of this study, which hails from the Mayo Clinic, said that when providers were asked if they were talking about end of life issues with their patients, many of them said they wait until things get bad or until they have to do something new, like start a medication or talk about more aggressive therapy. Instead of cutting to the chase at the get-go, giving patients the true information about their prognosis right away, patients are faced with it when things look grim, and when it’s likely to be an awful surprise.

This is the point where I step in: the bedside, ICU nurse. I see CHF patients when their heart is so tired that it can’t pump blood to the body any longer, and it backs up into their lungs. Fluid-filled lungs don’t function very well, so the patients end up having to decided if they want the support of a ventilator while they gulp for air and foam at the mouth in a vicious attempt to stay alive. How is this best-case scenario? I don’t know about you, but I’d prefer a quiet, calm doctor’s office for the setting of this chat, not the point where my life is hanging in the balance with a bunch of strangers and fear.

I sent out a tweet to the ‘sphere after reading this write up. I asked the question: “I wonder how many nurses are starting these conversations?” Almost in an eerie response to my query, the Robert Wood Johnson Foundation’s Human Capital Blog tweeted out a blog post about a recent CDC study saying that nurses and PA’s are more frequently giving patients chronic disease management education than physicians. It’s true; I often talk to my patients about their illnesses in honest ways, bringing up options different from their aggressive – and often futile – hospital care.

While CHF wasn’t one of the chronic conditions noted, the CDC study’s results were pretty jarring: less than 50% of patients receive education on their chronic condition. The reality of all chronic conditions, especially CHF, is that they eventually become acute. If we’re not talking about end of life in the beginning, and only half of us are educating in the duration, what, exactly, do patients know about their diagnoses?

Thanks to Hollywood and the silver screen, the public has been long familiar with the stereotypical oncologist prognosis scene: “Mr. Jones, you’ve got six months left to live,” are now common words in our vernacular. But rarely, if ever, do I hear people telling me about diagnoses with other chronic conditions (yes, cancer is a chronic condition) like CHF, tied to time-left-to-live quantifications.

Why not? Recognizing the possibility for death, starting at diagnosis, seems to bring motivation and acceptance in patients. CHF patients should be traveling the globe, checking off their bucket lists, planning for a proactive and comfortable death just as much as cancer patients seem to be. Until we stop cowering behind our fears of introducing end of life care as a part of chronic disease management, patients will continue to be cheated of a fair chance to live the life they have left to its attainable maximum.

Maybe all of us conversation-starters should remember: Hope is only helpful when directed at reality. Get chatting.

  [caption id="attachment_7805" align="alignright" width="300"] Nobody's talking: New

 

This guest post is by David Benton, Chief Executive Officer, International Council of Nurses. The International Council of Nurses (ICN) is a federation of more than 130 national nurses associations (NNAs), representing the more than 16 million nurses worldwide. 

fight_the_fakes_logo_with_tag_final_ol_2color_cmyk_SM

5 June 2014 Global Anti-Counterfeiting Day

In 2011, in Arizona, a nurse administering medication to a cancer patient was startled by his reaction to the drug – he began shaking in the middle of a transfusion and the infusion had to be discontinued.  The medicine, it turns out, was fake; a cocktail of salt, starch, acetone and a variety of other chemicals, and lacking the active ingredient of the real medicine. The fake drugs had been shipped to 19 US cancer clinics.

Unfortunately, this is not a unique case.  The United States Food and Drug Administration estimates that counterfeits make up more than 10% of the global medicines market and are present in both industrialized and developing countries. It is also estimated that one medicine in two purchased on Internet sites that hide their physical address is fake.

In 2009, Francis Ortiz Gonzalez was arrested when investigators found more than 100,000 pills made to resemble a variety of popular prescription medications, including Viagra, Cialis, Valium, Xanax and Lipitor.

Earlier this year, the UK’s Daily Mirror reported on black market abortion tablets which were being sold online to young teenage girls too scared to tell their parents they are pregnant.  These pills can kill if taken in the wrong dosage.

In order to combat this threat, the International Council of Nurses (ICN) has joined Fight the Fakes, the multi-stakeholder

 campaign which aims to raise awareness about the dangers of fake medicine by giving a voice to those who have been personally impacted and sharing the stories of those working to put a stop to this threat to public health. It seeks to build a global movement of organisations and individuals who will shine light on the negative impact that fake medicines have on people around the globe and to reduce the negative consequences on individuals worldwide.

ICN believes that if we are all aware of the existence of fake medicines and the dangers they pose, we will be better at putting pressure on our governments, and all those involved in the manufacturing and distribution of medicines, to coordinate actions to tackle this public health threat on a global level. 

Fake medicines put patients and the general public at risk. They trick patients into believing they are receiving genuine treatment, when instead they are getting deceitful products that could cause further illness, disability or even death. Furthermore, fake medicines pose a public health danger as they can contribute to the development of treatment resistance. And they undermine patients’ trust in health systems, their governments, health care providers and manufacturers of genuine medicines. 

JointFighttheFake-Infographic-1 (3)

 

  This guest post is by David Benton,

Linda Schwarz

Linda Schwarz

While the media ramps up coverage of Congressional calls for Secretary for Veterans Affairs Eric Shinseki’s resignation, the Senate ought to examine its own role in this crisis.

Two of three assistant secretary positions that have gone unfilled in the Veterans Administration, because they are awaiting Senate confirmation. Linda Schwartz was appointed last summer by President Obama to be Assistant Secretary for Policy and Planning.  A veteran and nurse, Dr. Schwartz is the Commissioner for Veterans Affairs in Connecticut. She served as a nurse in the Air Force during the Vietnam War before becoming disabled from a freak accident while on a cargo plane that left her disabled. She is unwavering in her commitment to serving the nation’s veterans.  To learn more about her story, watch this video that was produce by a student at Yale University.

On November 19, 2013, the Senate Committee on Veterans Affairs voted unanimously to support Schwartz’s appointment and she was expected to quickly be approved by the full Senate. Six months later, the full Senate has not even considered her nomination.

While Congress wants to hold Shinseki accountable for the excessive and unacceptable wait times for veterans using the VA health system, who will hold the Senate accountable for its delays in ensuring that the VA has the leadership it needs to fix this problem and prevent others from occurring?

 

Diana J. Mason, PhD, RN, FAAN, Rudin Professor of Nursing, Hunter College

 

 

 

 

[caption id="attachment_7790" align="alignleft" width="175"] Linda Schwarz[/caption] While the